Oruka Therapeutics (ORKA) EBIT Growth (3y) (2013 - 2024)
Oruka Therapeutics (ORKA) EBIT Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 13.58% |
| Mar 31, 2024 | 15.42% |
| Dec 31, 2023 | 32.31% |
| Sep 30, 2023 | 0.90% |
| Jun 30, 2023 | -14.63% |
| Mar 31, 2023 | -10.26% |
| Dec 31, 2022 | -6.60% |
| Sep 30, 2022 | -26.96% |
| Jun 30, 2022 | -28.76% |
| Mar 31, 2022 | -22.54% |
| Dec 31, 2021 | -54.94% |
| Sep 30, 2021 | -41.57% |
| Jun 30, 2021 | -30.91% |
| Mar 31, 2021 | -13.94% |
| Dec 31, 2020 | -6.06% |
| Sep 30, 2020 | 23.67% |
| Jun 30, 2020 | 38.23% |
| Mar 31, 2020 | 32.62% |
| Dec 31, 2019 | 33.22% |
| Sep 30, 2019 | 35.80% |